MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes
- PMID: 16574712
- DOI: 10.1177/0269881106063269
MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes
Abstract
In recent years working memory deficits have been reported in users of MDMA (3,4-methylenedioxymethamphetamine, ecstasy). The current study aimed to assess the impact of MDMA use on three separate central executive processes (set shifting, inhibition and memory updating) and also on "prefrontal" mediated social and emotional judgement processes. Fifteen polydrug ecstasy users and 15 polydrug non-ecstasy user controls completed a general drug use questionnaire, the Brixton Spatial Anticipation task (set shifting), Backward Digit Span procedure (memory updating), Inhibition of Return (inhibition), an emotional intelligence scale, the Tromso Social Intelligence Scale and the Dysexecutive Questionnaire (DEX). Compared with MDMA-free polydrug controls, MDMA polydrug users showed impairments in set shifting and memory updating, and also in social and emotional judgement processes. The latter two deficits remained significant after controlling for other drug use. These data lend further support to the proposal that cognitive processes mediated by the prefrontal cortex may be impaired by recreational ecstasy use.
Similar articles
-
Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.J Psychopharmacol. 2008 Jul;22(5):498-510. doi: 10.1177/0269881107081545. Epub 2008 Jan 21. J Psychopharmacol. 2008. PMID: 18208910
-
Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.Psychopharmacology (Berl). 2002 Jul;162(2):203-14. doi: 10.1007/s00213-002-1071-9. Epub 2002 May 9. Psychopharmacology (Berl). 2002. PMID: 12110998
-
Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.J Psychopharmacol. 2006 Mar;20(2):211-25. doi: 10.1177/0269881106059486. J Psychopharmacol. 2006. PMID: 16510479 Review.
-
MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.J Psychopharmacol. 2006 Mar;20(2):147-63. doi: 10.1177/0269881106063268. J Psychopharmacol. 2006. PMID: 16510474 Review.
-
Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls.J Psychopharmacol. 2006 Mar;20(2):302-11. doi: 10.1177/0269881106059495. J Psychopharmacol. 2006. PMID: 16510488 Clinical Trial.
Cited by
-
An in vivo microdialysis assessment of concurrent MDMA and cocaine administration in Sprague-Dawley rats.Psychopharmacology (Berl). 2010 Mar;209(1):95-102. doi: 10.1007/s00213-009-1774-2. Epub 2010 Jan 30. Psychopharmacology (Berl). 2010. PMID: 20112010
-
Equivalent effects of acute tryptophan depletion on REM sleep in ecstasy users and controls.Psychopharmacology (Berl). 2009 Oct;206(2):187-96. doi: 10.1007/s00213-009-1595-3. Epub 2009 Jul 8. Psychopharmacology (Berl). 2009. PMID: 19585107 Clinical Trial.
-
In-utero exposure to the popular 'recreational' drugs MDMA (Ecstasy) and Methamphetamine (Ice, crystal): preliminary findings.Clin Dev Med. 2011 Feb;188:169-182. Clin Dev Med. 2011. PMID: 35422536 Free PMC article. No abstract available.
-
(±)3,4-methylenedioxymethamphetamine ("ecstasy") treatment modulates expression of neurotrophins and their receptors in multiple regions of adult rat brain.J Comp Neurol. 2012 Aug 1;520(11):2459-74. doi: 10.1002/cne.23048. J Comp Neurol. 2012. PMID: 22237931 Free PMC article.
-
Dance clubbing on MDMA and during abstinence from Ecstasy/MDMA: prospective neuroendocrine and psychobiological changes.Neuropsychobiology. 2008;57(4):165-80. doi: 10.1159/000147470. Epub 2008 Jul 24. Neuropsychobiology. 2008. PMID: 18654086 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical